Immune Response to HPV16 E6 and E7 Proteins and Patient Outcomes in Head and Neck Cancer-Reference-Cited by-同舟云学术

Immune Response to HPV16 E6 and E7 Proteins and Patient Outcomes in Head and Neck Cancer

Published:2017-02-01 Issue:2 Volume:3 Page:178
ISSN:2374-2437
Container-title:JAMA Oncology
language:en
Short-container-title:JAMA Oncol

Author:

Nelson Heather H.¹,Pawlita Michael²,Michaud Dominique S.³,McClean Michael⁴,Langevin Scott M.⁵,Eliot Melissa N.⁶,Kelsey Karl T.⁷

Affiliation:

1. Masonic Cancer Center, University of Minnesota, Minneapolis2Division of Epidemiology and Community Health, University of Minnesota, Minneapolis

2. Research Program Infection and Cancer, German Cancer Research Center, DKFZ, Heidelberg, Germany

3. Department of Public Health and Community Medicine, Tufts University School of Medicine, Boston, Massachusetts

4. Department of Environmental Health, Boston University School of Public Health, Boston, Massachusetts

5. Department of Environmental Health, University of Cincinnati College of Medicine, Cincinnati, Ohio

6. Department of Epidemiology, Brown University, Providence, Rhode Island

7. Department of Epidemiology, Brown University, Providence, Rhode Island8Department of Pathology and Laboratory Medicine, Brown University, Providence, Rhode Island

Publisher

American Medical Association (AMA)

Subject

Oncology,Cancer Research

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multimodal assessment of high-risk human papillomavirus in sinonasal squamous cell carcinoma;Pathology - Research and Practice;2024-09

2. Type I interferon drives a cellular state inert to TCR-stimulation and could impede effective T-cell differentiation in cancer;2024-03-31

3. Immune-based classification of HPV-associated oropharyngeal cancer with implications for biomarker-driven treatment de-intensification;EBIOMEDICINE;2022

4. Immune-based classification of HPV-associated oropharyngeal cancer with implications for biomarker-driven treatment de-intensification;eBioMedicine;2022-12

5. The role of T-cells in head and neck squamous cell carcinoma: From immunity to immunotherapy;Frontiers in Oncology;2022-10-20